Member Info for researcher1

and he qualifies for some of those options when the SP gets to £4....

remember his holding remains unchanged - and £8M is, I'd say, a decent bit of skin in the game....

p.s. and of course if that quantity had been sold through normal markets, the price would have tanked.

he wouldn't be allowed to sell if there was bad news lurking, but would if there was good news to come. To find a buyer for so much at 125 is great news, so soon after the raise. I'm adding more this morning.

A gentlemanly action - AN totally deserves a bit of cash, and is selling in advance of a forthcoming spike that he knows everything about - he still has £8M in the company mind you....
by the way, what happened in tonight's match? :-)

Phantom, I understand what you are getting at, but actually I don't mind the drops at all, as they are a reminder that the share price hasn't even started yet. I also use T20s to keep a larger holding, so can amuse myself by trying to time buys and sells as the SP oscillates - though I know it is largely irrelevant to the larger trajectory.

I fancy a clinic contract announcement - the company are much more strategic in the timing of news releases these days...

thanks Bermuda - intriguing stats...

apologies, I meant 'clinical contracts'

I have the feeling that the next clinical announcement will take the SP over 150, to wait there for FDA....

pleased now with my 121 buy, but I had a larger chunk lined up for 118p - oh well....

it would be complementary - Parsortix is mainly deployed once a cancer is known about, to capture live CTC cells and provide treatment analysis - it would work downstream from the likes of Grail and this NHS test (if effective)...

best I could get was 121, so bought a few for fun

let's see - I imagine the MMs will open the spread to something like 118 - 123

I see it as a huge positive, though I do wish they'd invite us pis to the discount party. That said, maybe we can pick up some shares around 115 this morning... let's see... I expect the sp to end above 125 by close of play....

and even the Chinese are more respectful of medical patents, as they hold an extensive number themselves...

yes Buzz, agreed - even in the event of direct plagiarism, Angle are 3 to 4 years ahead in terms of development, peer review and, we expect, FDA approval.

curious micro-shake this morning following good news - I expect a large pi leaving for the summer? - could be risky!

yeah, it is dull - news is important - more clinical contracts should be along soon - but the FDA risk/reward is in play which has no relation to TA at all, especially when no one is sure of the time scale.

sorry to hear that Brex - an Angle (sic) will answer your prayers...